VOYA Investment Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,295
| Closed | -$34.2K | – | 2739 |
|
|
2024
Q3 | $34.2K | Hold |
3,295
| – | – | ﹤0.01% | 2796 |
|
|
2024
Q2 | $64.9K | Buy |
3,295
+283
| +9% | +$5.67K | ﹤0.01% | 2760 |
|
|
2024
Q1 | $77.1K | Buy |
3,012
+854
| +40% | +$21.9K | ﹤0.01% | 2671 |
|
|
2023
Q4 | $59.6K | Sell |
2,158
-19
| -0.9% | -$1.16K | ﹤0.01% | 2832 |
|
|
2023
Q3 | $132K | Hold |
2,177
| – | – | ﹤0.01% | 2663 |
|
|
2023
Q2 | $143K | Buy |
2,177
+230
| +12% | +$16.8K | ﹤0.01% | 2692 |
|
|
2023
Q1 | $124K | Buy |
1,947
+324
| +20% | +$37K | ﹤0.01% | 2662 |
|
|
2022
Q4 | $225K | Buy |
1,623
+93
| +6% | +$13.1K | ﹤0.01% | 2520 |
|
|
2022
Q3 | $194K | Sell |
1,530
-1,406
| -48% | -$159K | ﹤0.01% | 2615 |
|
|
2022
Q2 | $243K | Buy |
2,936
+102
| +4% | +$7.91K | ﹤0.01% | 2289 |
|
|
2022
Q1 | $275K | Buy |
2,834
+494
| +21% | +$65.2K | ﹤0.01% | 2211 |
|
|
2021
Q4 | $468K | Buy |
2,340
+265
| +13% | +$62.5K | ﹤0.01% | 2064 |
|
|
2021
Q3 | $514K | Buy |
2,075
+20
| +1% | +$5.72K | ﹤0.01% | 2031 |
|
|
2021
Q2 | $851K | Buy |
2,055
+893
| +77% | +$354K | ﹤0.01% | 1743 |
|
|
2021
Q1 | $454K | Sell |
1,162
-61
| -5% | -$30K | ﹤0.01% | 2089 |
|
|
2020
Q4 | $686K | Sell |
1,223
-52
| -4% | -$33K | ﹤0.01% | 1725 |
|
|
2020
Q3 | $891K | Sell |
1,275
-37
| -3% | -$28.9K | ﹤0.01% | 1343 |
|
|
2020
Q2 | $1.04M | Buy |
1,312
+552
| +73% | +$416K | ﹤0.01% | 1254 |
|
|
2020
Q1 | $452K | Buy |
760
+12
| +2% | +$11.7K | ﹤0.01% | 1675 |
|
|
2019
Q4 | $850K | Sell |
748
-6
| -0.8% | -$6.52K | ﹤0.01% | 1549 |
|
|
2019
Q3 | $897K | Sell |
754
-679
| -47% | -$1.04M | ﹤0.01% | 1389 |
|
|
2019
Q2 | $2.36M | Sell |
1,433
-593
| -29% | -$1.03M | 0.01% | 998 |
|
|
2019
Q1 | $4.13M | Sell |
2,026
-211
| -9% | -$372K | 0.01% | 846 |
|
|
2018
Q4 | $2.87M | Buy |
2,237
+46
| +2% | +$70.6K | 0.01% | 912 |
|
|
2018
Q3 | $4.14M | Buy |
2,191
+219
| +11% | +$452K | 0.01% | 881 |
|
|
2018
Q2 | $4.01M | Sell |
1,972
-13,109
| -87% | -$29.9M | 0.01% | 886 |
|
|
2018
Q1 | $33.4M | Sell |
15,081
-781
| -5% | -$1.99M | 0.07% | 282 |
|
|
2017
Q4 | $36.6M | Sell |
15,862
-9,901
| -38% | -$20.1M | 0.08% | 271 |
|
|
2017
Q3 | $45.8M | Buy |
25,763
+8,980
| +54% | +$12.5M | 0.1% | 216 |
|
|
2017
Q2 | $22.8M | Buy |
16,783
+15,541
| +1,251% | +$18.8M | 0.05% | 362 |
|
|
2017
Q1 | $1.46M | Buy |
1,242
+51
| +4% | +$52K | ﹤0.01% | 1152 |
|
|
2016
Q4 | $952K | Sell |
1,191
-16
| -1% | -$12.7K | ﹤0.01% | 1347 |
|
|
2016
Q3 | $1.06K | Hold |
1,207
| – | – | ﹤0.01% | 1276 |
|
|
2016
Q2 | $677K | Hold |
1,207
| – | – | ﹤0.01% | 1501 |
|
|
2016
Q1 | $664K | Sell |
1,207
-11
| -0.9% | -$6.76K | ﹤0.01% | 1520 |
|
|
2015
Q4 | $1.01M | Sell |
1,218
-35
| -3% | -$35K | ﹤0.01% | 1280 |
|
|
2015
Q3 | $1.39M | Buy |
1,253
+87
| +7% | +$159K | ﹤0.01% | 1143 |
|
|
2015
Q2 | $2.54M | Buy |
1,166
+264
| +29% | +$538K | 0.01% | 982 |
|
|
2015
Q1 | $1.41M | Buy |
902
+63
| +8% | +$83.1K | ﹤0.01% | 1260 |
|
|
2014
Q4 | $996K | Hold |
839
| – | – | ﹤0.01% | 1450 |
|
|
2014
Q3 | $390K | Hold |
839
| – | – | ﹤0.01% | 2063 |
|
|
2014
Q2 | $419K | Buy |
+839
| New | +$269K | ﹤0.01% | 2114 |
|
Other funds holding BLUE
APM
LPC
PHS
VOYA Investment Management's BLUE Position: Q4 2024 in Review
VOYA Investment Management sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 3,295 shares — an estimated $34.2K sold.
VOYA Investment Management first reported a position in BLUE in Q2 2014 and held it in 42 quarters. The position peaked at $45.8M in Q3 2017. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.
- VOYA Investment Management reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
- VOYA Investment Management sold 3,295 bluebird bio shares in Q4 2024, an estimated $34.2K.
- VOYA Investment Management first reported a position in bluebird bio in Q2 2014 and held it in 42 quarters.
- VOYA Investment Management's bluebird bio position peaked at $45.8M in Q3 2017.
- 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.
Based on VOYA Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.